Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies
批准号:
10665141
负责人:
Charlotte Jane Sumner
金额:
$16.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-13 至 2023-04-30
关键词:
Administrative SupplementAreaAutomobile DrivingAwardBiomedical ResearchCollaborationsCommunicationCommunitiesDataData AnalysesDevelopmentDiseaseDistal Spinal Muscular AtrophyEducational process of instructingExperimental DesignsFosteringFundingFutureGene TargetingGenerationsGenesGeneticGoalsGrantHourHuman GeneticsIndividualLaboratoriesLearningLiteratureMentorsMentorshipMolecularMolecular MedicineMotor Neuron DiseaseMuscle WeaknessMutationNational Institute of Neurological Disorders and StrokeNeurodegenerative DisordersNeuromuscular DiseasesNeurosciencesNotificationOralParentsPathologyPatientsPersonsProcessQuality of lifeReagentResearchResearch ProposalsResourcesSMN1 geneScienceScientistSpinal Muscular AtrophyStudentsTechniquesTechnologyTextTherapeuticTimeTrainingTraining SupportTransgenic MiceTranslatingTravelTreatment EfficacyUniversitiesVanilloidWagesWorkWritingcareercostearly onsetexperiencegraduate studentimprovedinduced pluripotent stem celljournal articleloss of function mutationmedical schoolsmeetingsmortalitynovelnovel therapeutic interventionpeer coachingprogramsreceptorskillstargeted treatmentundergraduate student
中文摘要
项目摘要
脊髓性肌萎缩症(SMA)是单基因运动神经元(MN)疾病,导致肌肉衰弱
虚弱且通常过早死亡。我们的研究计划侧重于推进两种形式的
SMA:由运动神经元生存基因1(SMN1)的隐性功能丧失突变引起的近端SMA
和由瞬时受体电位香草酸4基因显性突变引起的远端SMA(dSMA)
(TRPV4)。这是对我的R35补助金的行政补充,由NINDS Landis导师奖资助,
为约翰霍普金斯大学的四名研究生提供指导和培训
医学院的长期目标是培养他们未来在生物医学方面的职业生涯,
神经退行性疾病的治疗。每个学生将追求一个研究生论文项目,是在
在父母R35补助金中提出的研究范围:Stephen Brown和Maddie Dent将专注于近端
SMA和安娜巴格内尔和乔纳森阿列维将重点关注远端SMA。他们将利用独特的资源,
最先进的技术,以确定限制当前SMA治疗有效性的因素,表征细胞
以及驱动SMA病理的分子机制,并确定和验证新的治疗策略。在
为了促进他们的培训,补编的第一个目标是为科学家提供定期的一对一会议,
讨论包括相关文献综述、假设生成、实验设计和数据
解释。第二个目标是通过使他们能够利用尖端的实验技术来促进他们的培训。
技术来追求他们的科学假设。第三个目标是支持学生前往科学
第四个目标是为“同行”建立一个丰富的受训者社区,
指导。
英文摘要
PROJECT SUMMARY
Spinal muscular atrophies (SMAs) are monogenetic motor neuron (MN) diseases that cause debilitating muscle
weakness and often early mortality. Our research program focuses on advancing therapeutics for two forms of
SMA: proximal SMA caused by recessive, loss-of-function mutations of the survival motor neuron 1 gene (SMN1)
and distal SMA (dSMA) caused by dominant mutations of the transient receptor potential vanilloid 4 gene
(TRPV4). This administrative supplement to my R35 grant funded by the NINDS Landis Mentorship Award will
provide funds to augment the mentorship and training of four graduate students at Johns Hopkins University
School of Medicine with the long-term goal of fostering their future careers in biomedicine working to advance
treatment for neurodegenerative diseases. Each student will pursue a graduate thesis project that is within the
scope of research proposed in the parent R35 grant: Stephen Brown and Maddie Dent will focus on proximal
SMA and Anna Bagnell and Jonathan Alevy will focus on distal SMA. They will leverage unique resources and
state-of-the-art technologies to define factors limiting efficacy of current SMA therapeutics, characterize cellular
and molecular mechanisms driving SMA pathology, and identify and validate novel therapeutic strategies. In
order to foster their training, the first aim of the supplement is to provide regular one-on-one meetings for scientific
discussion including review of relevant literature, hypothesis generation, experimental design, and data
interpretation. The second aim to foster their training by enabling them to utilize cutting-edge experimental
techniques to pursue their scientific hypotheses. The third aim is to support travel of students to scientific
meetings for presentations and networking and the fourth aim is to create a rich community of trainees for “peer”
mentoring.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Correction to: Peripheral Neuropathy: No Longer the Land of Therapeutic Nihilism.
更正:周围神经病变:不再是治疗虚无主义的土地。
DOI:
10.1007/s13311-022-01187-x
发表时间:
2022
期刊:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
影响因子:
--
作者:
[Polydefkis,Michael, Sumner,CharlotteJ]
通讯作者:
Sumner,CharlotteJ
DOI:
10.1038/s41591-022-01889-x
发表时间:
2022-07
期刊:
NATURE MEDICINE
影响因子:
82.9
作者:
[Sumner, Charlotte J., Crawford, Thomas O.]
通讯作者:
Crawford, Thomas O.
DOI:
10.3233/jnd-230054
发表时间:
2023
期刊:
JOURNAL OF NEUROMUSCULAR DISEASES
影响因子:
3.3
作者:
[Glascock, Jacqueline, Darras, Basil T., Crawford, Thomas O., Sumner, Charlotte J., Kolb, Stephen J., DiDonato, Christine, Elsheikh, Bakri, Howell, Kelly, Farwell, Wildon, Valente, Marta, Petrillo, Marco, Tingey, Jessica, Jarecki, Jill]
通讯作者:
Jarecki, Jill
DOI:
10.1002/acn3.51523
发表时间:
2022-03
期刊:
Annals of clinical and translational neurology
影响因子:
5.3
作者:
[Taga A, Peyton MA, Goretzki B, Gallagher TQ, Ritter A, Harper A, Crawford TO, Hellmich UA, Sumner CJ, McCray BA]
通讯作者:
McCray BA
DOI:
10.1186/s40478-023-01551-8
发表时间:
2023-03-30
期刊:
ACTA NEUROPATHOLOGICA COMMUNICATIONS
影响因子:
7.1
作者:
[Kong, Lingling, Hassinan, Cera W., Gerstner, Florian, Buettner, Jannik M., Petigrow, Jeffrey B., Valdivia, David O., Chan-Cortes, Michelle H., Mistri, Amy, Cao, Annie, McGaugh, Scott Alan, Denton, Madeline, Brown, Stephen, Ross, Joshua, Schwab, Markus H., Simon, Christian M., Sumner, Charlotte J.]
通讯作者:
Sumner, Charlotte J.
共 10 条
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies
-
批准号:10401905
-
项目类别:
-
资助金额:$100.2万
-
财政年份:2021
-
负责人:Charlotte Jane Sumner
-
依托单位:
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies
-
批准号:10239537
-
项目类别:
-
资助金额:$105.88万
-
财政年份:2021
-
负责人:Charlotte Jane Sumner
-
依托单位:
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies
-
批准号:10611992
-
项目类别:
-
资助金额:$100.2万
-
财政年份:2021
-
负责人:Charlotte Jane Sumner
-
依托单位:
TRPV4 links the blood-neural barrier to motor neuron dysfunction
-
批准号:9916170
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2020
-
负责人:Charlotte Jane Sumner
-
依托单位:
Impaired axon development in SMA
-
批准号:9899329
-
项目类别:
-
资助金额:$41.75万
-
财政年份:2018
-
负责人:Charlotte Jane Sumner
-
依托单位:
A model of TRPV4 channelopathy
-
批准号:8684485
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2014
-
负责人:Charlotte Jane Sumner
-
依托单位:
Muscle and neuromuscular junctions in spinal muscular atrophy
-
批准号:8457123
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2009
-
负责人:Charlotte Jane Sumner
-
依托单位:
Muscle and neuromuscular junctions in spinal muscular atrophy
-
批准号:8249387
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2009
-
负责人:Charlotte Jane Sumner
-
依托单位:
Muscle and neuromuscular junctions in spinal muscular atrophy
-
批准号:7652226
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2009
-
负责人:Charlotte Jane Sumner
-
依托单位:
Muscle and neuromuscular junctions in spinal muscular atrophy
-
批准号:8047943
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2009
-
负责人:Charlotte Jane Sumner
-
依托单位:
Regulation of the survival motor neuron gene
-
批准号:7433864
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2006
-
负责人:Charlotte Jane Sumner
-
依托单位:
Regulation of the survival motor neuron gene
-
批准号:7294973
-
项目类别:
-
资助金额:$19.09万
-
财政年份:2006
-
负责人:Charlotte Jane Sumner
-
依托单位:
Regulation of the survival motor neuron gene
-
批准号:6762119
-
项目类别:
-
资助金额:$18.86万
-
财政年份:2006
-
负责人:Charlotte Jane Sumner
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: